Template:Dgfn2015 So 13:00 Mittagssymposium Nr.2, ..ANCA assoziierte Vaskulitiden
(Difference between revisions)
Ossip Groth (Talk | contribs) |
Ossip Groth (Talk | contribs) |
||
| Line 25: | Line 25: | ||
??DMW 2014 mossig nicht im pm?? | ??DMW 2014 mossig nicht im pm?? | ||
---- | ---- | ||
| − | + | {{tp|p=24831059|t=2014. Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis |pdf=http://rheumatology.oxfordjournals.org/content/early/2014/05/15/rheumatology.keu194.full.pdf+html|usr=}} | |
{{tp|p=23497590|t=2013. Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=23497590&pmc=3607855&ti=Plasma%20exchange%20and%20glucocorticoid%20dosing%20in%20the%20treatment%20of%20anti-neutrophil%20cytoplasm%20antibody%20associated%20vasculitis%20%28PEXIVAS%29:%20protocol%20for%20a%20randomized%20controlled%20trial|usr=}} | {{tp|p=23497590|t=2013. Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial |pdf=http://sm.kidney.de/epmc.php?ep=eu&pmid=23497590&pmc=3607855&ti=Plasma%20exchange%20and%20glucocorticoid%20dosing%20in%20the%20treatment%20of%20anti-neutrophil%20cytoplasm%20antibody%20associated%20vasculitis%20%28PEXIVAS%29:%20protocol%20for%20a%20randomized%20controlled%20trial|usr=}} | ||
| Line 31: | Line 31: | ||
{{tp|p=25986911|t=2015. Role of therapeutic plasmapheresis in ANCA-associated vasculitis |pdf=http://link.springer.com/content/pdf/10.1007%2Fs00467-014-3038-6.pdf|usr=}} | {{tp|p=25986911|t=2015. Role of therapeutic plasmapheresis in ANCA-associated vasculitis |pdf=http://link.springer.com/content/pdf/10.1007%2Fs00467-014-3038-6.pdf|usr=}} | ||
---- | ---- | ||
| − | + | {{tp|p=23902481|t=2013. Efficacy of remission-induction regimens for ANCA-associated vasculitis |pdf=http://www.nejm.org/doi/pdf/10.1056/NEJMoa1213277|usr=}} | |
| + | {{tp|p=24195565|t=2013. Induction regimens for ANCA-Associated Vasculitis |pdf=http://www.nejm.org/doi/pdf/10.1056/NEJMc1311108|usr=}} | ||
| + | |||
{{tp|p=25776953|t=2015. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids |pdf=http://www.researchgate.net/profile/Fernando_Fervenza/publication/273703229_Outcomes_of_non-severe_relapses_in_ANCA-associated_vasculitis_treated_with_glucocorticoids/links/552297d40cf2a2d9e14573c8.pdf|usr=}} | {{tp|p=25776953|t=2015. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids |pdf=http://www.researchgate.net/profile/Fernando_Fervenza/publication/273703229_Outcomes_of_non-severe_relapses_in_ANCA-associated_vasculitis_treated_with_glucocorticoids/links/552297d40cf2a2d9e14573c8.pdf|usr=}} | ||
| Line 65: | Line 67: | ||
??author?j... nejm 2003 | ??author?j... nejm 2003 | ||
| − | + | {{tp|p=24646464|t=2014. Granulomatosis with polyangiitis (Wegener s): impact of maintenance therapy duration |pdf=http://www3.med.unipmn.it/papers/2014/LWW/2014-05-13_lww/Granulomatosis_With_Polyangiitis__Wegener_s__.3.pdf|usr=}} | |
| + | {{tp|p=23902481|t=2013. Efficacy of remission-induction regimens for ANCA-associated vasculitis |pdf=http://www.nejm.org/doi/pdf/10.1056/NEJMoa1213277|usr=}} | ||
| + | {{tp|p=24195565|t=2013. Induction regimens for ANCA-Associated Vasculitis |pdf=http://www.nejm.org/doi/pdf/10.1056/NEJMc1311108|usr=}} | ||
| + | {{utp|p=25739829|t=2015. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial |pdf=http://ard.bmj.com/content/74/6/1178.abstract|usr=}} | ||
| + | {{tp|p=25805743|t=2015. Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis |pdf=http://ndt.oxfordjournals.org/content/30/suppl_1/i123.full.pdf|usr=}} | ||
| + | |||
| + | ??ar 2014 azar? | ||
| + | |||
| + | {{tp|p=25372085|t=2014. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis |pdf=http://www.nejm.org/doi/pdf/10.1056/NEJMoa1404231|usr=}} | ||
| + | |||
| + | {{tp|p=25477054|t=2015. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis |pdf=http://rheumatology.oxfordjournals.org/content/54/7/1153.full.pdf+html|usr=}} | ||
| + | |||
| + | ??yusuf ard 2015 gbt es nicht?? | ||
| + | |||
| + | {{tp|p=25609739|t=2015. Maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: who needs what and for how long?|pdf=http://ndt.oxfordjournals.org/content/30/suppl_1/i150.full.pdf|usr=}} | ||
| + | {{tp|p=24729399|t=2014. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis |pdf=http://rheumatology.oxfordjournals.org/content/53/12/2306.full.pdf|usr=}} | ||
| + | {{tp|p=24108586|t=2014. Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy |pdf=http://rheumatology.oxfordjournals.org/content/53/1/145.full.pdf|usr=}} | ||
| + | |||
| + | ??ndt 2015 kronbille?? | ||
| + | |||
| + | ??ro 2013 benardi?? | ||
| + | |||
| + | {{tp|p=25381425|t=2015. Understanding the role of rituximab in ANCA GN: regressing toward the mean |pdf=http://jasn.asnjournals.org/content/26/4/771.long|usr=}} | ||
| + | |||
| + | {{utp|p=24703438|t=2014. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener s) Results of a single-center cohort study on 66 patients |pdf=http://www.sciencedirect.com/science/article/pii/S0896841114000663|usr=}} | ||
| + | |||
| + | ===Update zur Diagnostik ANCA-assoziierter Vaskulitiden=== | ||
| + | [http://nephrologie.conference2web.com/users/7715 Fleck-M] | ||
| + | Zettel verlegt. Gibt aber webcast. | ||
Revision as of 20:53, 27 September 2015
Contents |
So 13:00 Mittagssymposium Nr.2, ..ANCA assoziierte Vaskulitiden
Begrüßung
| Journal article, free access |
| GET 2013. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides Extract PDF direct |
| Weblink noncommercial {{{c}}} |
| 1990 ARA Claasification Issue 33(8), AR |
| Journal article, free access |
| GET 2011. Improved outcome in 445 patients with Wegener s granulomatosis in a German vasculitis center over four decades Extract PDF direct |
?? 2015 schrine j??
?? internist 2016 holle ?
Aktuelle Leitlinien und Ausblicke zur Therapie ANCA-assoziierter Vaskulitiden mit Rituximab
??Brock et al.
| Journal article, free access |
| GET 2009. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis Extract PDF direct |
| Journal article, free access |
| GET 2009. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients Extract PDF direct |
??Schöhermarck ar 2014??
| Journal article, free access |
| GET 2015. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement Extract PDF direct |
??DMW 2014 mossig nicht im pm??
| Journal article, free access |
| GET 2014. Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis Extract PDF direct |
| Journal article, free access |
| GET 2013. Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial Extract PDF direct |
| Journal article, free access |
| GET 2014. Rituximab in the treatment of anti-neutrophil cytoplasm antibody-associated vasculitis Extract PDF direct |
| Journal article, free access |
| GET 2015. Role of therapeutic plasmapheresis in ANCA-associated vasculitis Extract PDF direct |
| Journal article, free access |
| GET 2013. Efficacy of remission-induction regimens for ANCA-associated vasculitis Extract PDF direct |
| Journal article, free access |
| GET 2013. Induction regimens for ANCA-Associated Vasculitis Extract PDF direct |
| Journal article, free access |
| GET 2015. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids Extract PDF direct |
(( This article reviews 9 challenging vasculitis mimickers: fibromuscular dysplasia, calciphylaxis, segmental arterial mediolysis, antiphospholipid syndrome, hypereosinophilic syndrome, lymphomatoid granulomatosis, malignant atrophic papulosis, livedoid vasculopathy, and immunoglobulin G4-related disease.))
??ar 2012 carh cebae?????
| Journal article, free access |
| GET 2012. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis Extract PDF direct |
für hopn - scleroderm:
| Journal article, free access |
| GET 2012. Timing of transition between capillaroscopic patterns in systemic sclerosis Extract PDF direct |
??ard 2015 yusof??
Aktuelle Daten zur Erhaltungstherapie ANCA-assoziierter Vaskulitiden
| Journal article, free access |
| GET 2008. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force Extract PDF direct |
| Journal article, free access |
| GET 2007. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis Extract PDF direct |
| Journal article, free access |
| GET 2007. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies Extract PDF direct |
| Journal article, free access |
| GET 2014. Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis Extract PDF direct |
| Journal Paper, restricted access |
| GET 2013. Maintenance of clinical remission in ANCA-associated vasculitis Extract PDF direct |
| Journal article, free access |
| GET 2012. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis Extract PDF direct |
??rheumatology 2010 despujol??
| Journal article, free access |
| GET 2008. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts Extract PDF direct |
| Journal Paper, restricted access |
| GET 2005. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis Extract PDF direct |
| Journal Paper, restricted access |
| GET 2003. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study Extract PDF direct |
| Journal Paper, restricted access |
| GET 2005. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis Extract PDF direct |
??author?j... nejm 2003
| Journal article, free access |
| GET 2014. Granulomatosis with polyangiitis (Wegener s): impact of maintenance therapy duration Extract PDF direct |
| Journal article, free access |
| GET 2013. Efficacy of remission-induction regimens for ANCA-associated vasculitis Extract PDF direct |
| Journal article, free access |
| GET 2013. Induction regimens for ANCA-Associated Vasculitis Extract PDF direct |
| Journal Paper, restricted access |
| GET 2015. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial Extract PDF direct |
| Journal article, free access |
| GET 2015. Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis Extract PDF direct |
??ar 2014 azar?
| Journal article, free access |
| GET 2014. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis Extract PDF direct |
| Journal article, free access |
| GET 2015. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis Extract PDF direct |
??yusuf ard 2015 gbt es nicht??
| Journal article, free access |
| GET 2015. Maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: who needs what and for how long? Extract PDF direct |
| Journal article, free access |
| GET 2014. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis Extract PDF direct |
| Journal article, free access |
| GET 2014. Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy Extract PDF direct |
??ndt 2015 kronbille??
??ro 2013 benardi??
| Journal article, free access |
| GET 2015. Understanding the role of rituximab in ANCA GN: regressing toward the mean Extract PDF direct |
| Journal Paper, restricted access |
| GET 2014. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener s) Results of a single-center cohort study on 66 patients Extract PDF direct |
Update zur Diagnostik ANCA-assoziierter Vaskulitiden
Fleck-M Zettel verlegt. Gibt aber webcast.
